Editorial · 31 Dec 2025
Mini reviewPublished 29 Oct 2021
A Review on Ageusia and Anosmia of COVID-19 Infection
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There is now abundant evidence that loss of sense of smell is one of the most common symptoms of COVID-19 infection and in some cases the only symptom. It is the best predictor of COVID-19 status of all the associated symptoms. Some months after the first reports of the potential value of loss of smell as a diagnostic marker, loss of, or change in, normal sense of smell (anosmia) or taste (ageusia) were included in the UK case definition, allowing patients access to testing and prompting self-isolation.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Research & Reviews: Journal of Hospital and Clinical Pharmacy.
Editorial · 31 Dec 2025
Clinical Guidelines: Standardizing Care for Improved Patient Outcomes
Editorial · 31 Dec 2025
Quality Improvement and Evidence-Based Practice: Enhancing Healthcare Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalResearch & Reviews: Journal of Hospital and Clinical Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sowparnika Treasa Sabu”